DWN12088 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
85特発性間質性肺炎3

85. 特発性間質性肺炎


臨床試験数 : 598 薬物数 : 435 - (DrugBank : 116) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 210
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04888715
(ClinicalTrials.gov)
July 23, 202128/4/2021To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy VolunteersAn Open Label, 2-part, One-sequence, 3-period Study to Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy VolunteersIdiopathic Pulmonary FibrosisDrug: DWN12088;Drug: Pirfenidone;Drug: NintedanibDaewoong Pharmaceutical Co. LTD.NULLCompleted19 Years55 YearsAll48Phase 1Korea, Republic of
2NCT04888728
(ClinicalTrials.gov)
June 30, 202128/4/2021To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy VolunteersAn Open Label, 2-part, One-sequence, 3-period Study to Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Male VolunteersIdiopathic Pulmonary FibrosisDrug: DWN12088;Drug: Nebivolol;Drug: ParoxetineDaewoong Pharmaceutical Co. LTD.NULLCompleted20 Years55 YearsMale24Phase 1Korea, Republic of
3NCT04767815
(ClinicalTrials.gov)
March 22, 202115/2/2021To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult VolunteersA Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics and Safety After Oral DWN12088 Administration in Healthy Adult VolunteersIdiopathic Pulmonary FibrosisDrug: Diet A group;Drug: Diet B group;Drug: Diet C groupDaewoong Pharmaceutical Co. LTD.NULLCompleted19 Years55 YearsAll36Phase 1Korea, Republic of